Roche sponsor early breast cancer leaflet
November 10, 2006Medical Communications
Roche is backing a new leaflet designed to help patients with newly diagnosed early breast cancer make sense of the …
US Democrats to target pharmaceutical prices
November 10, 2006Sales and Marketing
The decisive victory of the Democrat party in the US mid-term elections looks set to bring new pressure on pharmaceutical …
UK biotech comes to market
November 10, 2006Research and Development biotech, investment
At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …
Sepsis drug put back at least two years
November 9, 2006Research and Development
AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …
‘Pulsed’ vitamin D drug could transform advanced prostate cancer treatment
November 9, 2006Research and Development
American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …
Abbott buys cholesterol drug specialists Kos
November 9, 2006Sales and Marketing
Abbott is to pay $3.7 billion for Kos, the specialist US pharma company which has developed a number of major …
Novartis to be first pharma to conduct R&D in China
November 7, 2006Research and Development Asia, China, Novartis, em
Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …
Once-a-day colitis drug could take on the leaders
November 7, 2006Sales and Marketing
Shire is hoping its new, one-a-day treatment approach for ulcerative colitis (UC) will give the market leaders a run for …
First class relationships
November 6, 2006Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma
Pharma goes 'no frillls'Provocative headlines drawing attention to inappropriate behaviour and misconduct in the medical and pharmaceutical professions have been …
New drive to cut millions from branded sales on NHS
November 3, 2006Sales and Marketing generics
Some of the UK's top selling medicines are to be targeted in a new NHS drive to cut millions from …
New clinical trials agreement to improve UK research
November 3, 2006Research and Development
The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …
Teva and Schering-Plough UK to collaborate on bowel drug
November 3, 2006Sales and Marketing
Teva has signed a deal with Schering-Plough UK to co-promote its ulcerative colitis and Crohn's disease treatment, Mesren.Teva hopes that …
UK industry launches ‘manifesto’ to speed uptake of new medicines
November 2, 2006Sales and Marketing
Pharmaceutical industry organisation, the ABPI, has launched a new campaign to increase the uptake of new medicines in the UK, …
NHS staff unite in protest against government policies
November 1, 2006NHS employees from across England gathered in Westminster to protest against government reforms and cuts to the health service, which …
GSK suffers pipeline setbacks
November 1, 2006Research and Development
A series of problems with GlaxoSmithKline's late stage product pipeline has taken the shine off its third quarter figures.The company …
Pharma’s evolving relationship with NICE
November 1, 2006Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare
Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …
Has pharma got the feelgood factor?
October 30, 2006Business Services HR, recruitment
People are expecting more from their jobs than they ever have before. The concept of a job for life – …
Modified mice could speed safe drug discoveries
October 27, 2006Research and Development
CXR Biosciences, based in Scotland, and Artemis Pharmaceuticals in Germany, have been granted licences to sell their genetically modified mice, …
Protest against NHS cuts gathers momentum
October 26, 2006Protests against planned cuts to NHS services are taking place around the UK, with anger rising in a number of …
Most PCTs not funding Pfizer’s Macugen
October 26, 2006Patients with wet, age-related macular degeneration are being denied access to the first of a new class of treatment for …
Latest content
FibroFind appoints Lee Borthwick as CEO
